CMR Surgical Ltd. hopes to soon gain U.S. FDA 510(k) clearance for its Versius Plus surgical robotic system to bring it to the U.S. market amid rising demand for robotic surgery. Although the ...
Following Recent FDA Clearance for Cholecystectomy, the Company is now 510(k) pending for Gynecology. This Submission Builds On Extensive Global Clinical Experience in Gynecology and Continues CMR’s U ...
The MarketWatch News Department was not involved in the creation of this content. Cambridge-based surgical robotics company contributes majority of surgical data to world's largest open healthcare ...
CMR Surgical’s Versius surgical robot has received a European CE and UKCA marks for paediatric surgery, unlocking a new market segment for the UK-based company. Building on the CE mark initially ...
A new robotic-assisted surgery programme at St John’s Hospital in the heart of Limerick city has broadened patient access to ...
Versius-the second most utilised soft tissue surgical robot in the world i-has now been used in over 30,000 surgical cases globally across a broad range of specialties including urology, general ...
Cambridge, United Kingdom. 20 September 2023 0700 (BST). CMR Surgical (CMR or ‘the Company’) – the global surgical robotics business – has today announced that its next-generation Versius ® Surgical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results